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The PLoS Medicine Debate
Background to the debate: The global burden of disease falls disproportionately upon the world’s low-income 
countries, which are often struggling with weak health 
systems. Both the public and private sector deliver health 
care in these countries, but the appropriate role for each 
of these sectors in health system strengthening remains 
controversial. This debate examines whether the private 
sector should step up its involvement in the health systems 
of low-income countries.
Viewpoint by Kara Hanson, Lucy Gilson, 
Catherine Goodman, and Anne Mills: There Is No 
Alternative to Strengthening the Public Role in 
the Health System
Is private health care the answer for the world’s poor? 
Our starting point is that there are no strong grounds for 
assuming the superiority of either public or private health 
care. Theory tells us that it is not whether a health facility is 
publicly or privately owned that determines health provider 
performance. Instead, what influences performance is the 
nature of incentives that providers face and the quality of 
management and oversight. Theory does, however, suggest 
that the profit-making incentive dominant in much of the 
private sector is likely to be problematic for health care. 
Indeed, the reasons why private health care markets fail can 
be found in any introductory health economics text: (1) key 
preventive and public health services that produce external 
benefits (for example, prevention of spread of communicable 
disease or reduction in spread of antimicrobial resistance) 
will tend to be under-provided by private markets because 
these additional benefits are not valued in the market 
transaction; and (2) the patient’s lack of technical knowledge, 
and the role of health providers in directing patient care, 
leave patients vulnerable to low-quality treatment, excessive 
use of diagnostics, and over-prescription. 
However, empirical evidence on the performance of 
the two sectors also gives no clear guide to policy. In many 
settings, governments fail to provide health workers with 
incentives for good performance, offering health services of 
inadequate quality and allowing working environments to 
persist that engender uncaring and unresponsive attitudes 
amongst providers. Counter-intuitively, the public sector may 
even be inequitable, with some public services, especially 
at secondary and tertiary levels, disproportionately used by 
urban middle classes. At the same time, the private sector 
cannot be conceptualised as a single entity as there is a 
vast range of private providers operating throughout the 
low- and middle-income world. Private health services range 
from sophisticated inpatient facilities delivering advanced 
medical care of the highest international standard, through 
to the individual practices of doctors, nurses, and midwives, 
sometimes working in parallel with their public practice, and 
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to unqualified peddlers of drugs from market stalls. What 
evidence there is suggests that poor people are more likely to 
use the lower-quality, highly dispersed, and fragmented end 
of this spectrum. 
There is some limited evidence that the services of 
private providers can be improved through targeted quality 
improvement approaches [1]. But such projects have 
mostly operated at a relatively small scale, and have yet to 
demonstrate their ability to deliver improved population 
health. And such approaches have tended to engage with 
those parts of the private sector that are the easiest to 
organise—for example, those represented by recognised 
professional organisations—and less often with the informal, 
low-cost sources of care that provide the bulk of care to the 
poorest. The evidence reviewed in an International Finance 
Corporation publication on the private health sector in 
Africa supports the conclusion that existing initiatives have 
been limited in scale and focused on the more formal private 
health care sector [2]. 
Moreover, even where private services are low cost, they 
are not necessarily affordable. The evidence is clear that 
even short bouts of illness can have a catastrophic impact 
on welfare when households are very poor, threatening to 
undermine their livelihoods, and this impact is compounded 
in the case of chronic illness [3]. How health care is paid for 
is therefore crucial in assessing health care performance. But 
there is no evidence that private risk sharing schemes such 
as commercial insurance can reach the poorest groups, and 
the limited and seasonal cash income of these groups is likely 
to hamper attempts to include them in such schemes. While 
there are a few notable exceptions (such as Rwanda, where 
external resources have been used to expand insurance 
coverage), the reach of community-based insurance schemes 
has been very modest. There is therefore no alternative to 
strengthening the public role in financing health care, which 
can help achieve protection both against the cost of care and 
also against loss of income caused by illness. 
Is there then scope for private providers to be paid through 
public financing? This arrangement requires some form of 
contract to act as a mechanism to (1) transfer public funds to 
private providers, (2) determine which health services should 
be provided by the contractor, and (3) monitor performance. 
The still-limited evidence on such arrangements includes 
interesting examples of contracts between the public sector 
and private non-governmental organisations in fragile states, 
such as Afghanistan [4]. But these, and wider contracting 
experiences, all point to the significant transactions costs 
of such arrangements and the need for strong and capable 
contracting units within health ministries [5].
Responding to the health needs of the poorest will require 
a major scale-up of coverage of good-quality primary care, 
referral to first-level hospital care, and mechanisms to protect 
poor households from catastrophic health care payments. 
But context will influence what role private providers play: 
in some environments, ensuring quality care through private 
provision may prove effective in reaching the poorest. In 
other settings, it may be more appropriate to focus on 
improving the way that public providers operate, by building 
supply chains, strengthening incentives to support good 
performance, and improving the quality of supervision and 
performance management. And in every context where 
private providers operate, governments need to oversee and 
regulate the health sector as a whole, including both public 
and private providers.
Identifying the appropriate roles for public and private 
health care sectors is challenging, and many questions 
remain about how best this can be achieved. What are the 
key capacities needed by governments to oversee the health 
sector? How do these vary by context, particularly in the face 
of uneven state capacity? And what forms of intervention are 
most effective at improving the performance of providers, 
both public and private? Building stronger health systems will 
require more innovation, more learning-by-doing, and more 
careful evaluation to understand what works and why, before 
it will be possible for countries to reach a firm conclusion 
about what range of solutions offer the most promise for the 
world’s poor. 
Viewpoint by Richard Smith, Richard Feachem, 
Neelam Sekhri Feachem, Tracey Perez 
Koehlmoos, and Heather Kinlaw: We Must 
Engage the Private Sector to Improve Health 
Care in Low-Income Countries
In low-income countries today the private sector is a 
significant actor in health care—just as it is in high-income 
countries. Here we define the private sector as everything 
that is not the public sector, including non-governmental 
and faith-based organisations, social enterprises, for-profit 
companies, and a host of individual private providers in the 
formal and informal sectors. The private sector’s role in 
health care should be strengthened and more closely aligned 
with the public interest. Indeed, a question recently posed 
by Anne Mills and colleagues is not how governments can 
finance and provide all health services, but instead how can 
private sector activities “be influenced so that they can help 
meet national objectives?” [6]. In recent years, there has 
been growing agreement in the international community 
that addressing health needs in developing countries and 
achieving the Millennium Development Goals requires that 
governments and donors actively engage with the private 
sector [7,8]. To have a national impact, true partnerships 
between governments and the private sector must be created 
that go well beyond the contracting out of basic services such 
as laundry or housekeeping to private companies. 
Being pro–private sector does not imply being anti–public 
sector. The core of our argument is that, with a complicated 
problem such as improving health care under constrained 
resources, two heads are better than one. The public and 
private sectors have different strengths and weaknesses, and 
a judicious blending of the two can produce optimal results. 
Indeed, there is no health system that is entirely public or 
private [9]. Even in Britain, a country with an exceptionally 
high proportion of public spending, 13% of the health care 
spending in 2006 was private [10].
Significant amounts of public expenditure also go to the 
private sector in Britain and elsewhere. No “public” system 
produces its own drugs or equipment, and increasingly, 
governments in low- and middle-income countries are 
turning to the private sector to improve quality and deliver 
value for money. In China, Egypt, Lesotho, Mexico, Papua 
New Guinea, and South Africa, policy makers are partnering 
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with the private sector to build infrastructure, provide staff 
and training, raise quality, improve productivity, undertake 
social marketing, enhance procurement, and much more 
[11,12].
The reality is that in most low-income countries, most 
people receive most of their care from the broadly defined 
private sector. About 60% of the US$16.7 billion spent on 
health in sub-Saharan Africa in 2005 was private, most of it 
out-of-pocket spending by individuals, and about half of this 
went to private providers [2]. This spending on the private 
sector is particularly pronounced in the lowest-income 
countries in sub-Saharan Africa [8]. In Afghanistan and 
India, about 80% of care is provided by the private sector 
[11]. Often it is the poorest who are most likely to use private 
providers: in South Asia, 80% of children in the lowest 
income quintile who have acute respiratory conditions and 
are brought for care use a private provider [13]; while in 
Africa about 50% of those who seek care outside the home go 
to private providers [14]. 
In some low- and middle-income countries, limited 
mechanisms already exist for engaging the private sector 
in accreditation, contracting, training, and the area of 
social franchising, which seeks to replicate the success of 
commercial franchising but for a social benefit [15].
Despite these experiences, systematic evidence on the 
effectiveness of encouraging the private sector in developing 
countries is sparse—because stewardship of the private sector 
may be weak, programmes may not have been evaluated, 
and results may not be published. Although many articles 
have emerged recently on private sector approaches, 
particularly on contracting and social franchising [1,16–21], 
it is hard to reach a confident conclusion from these studies. 
Nevertheless, there is undoubtedly widespread enthusiasm for 
social franchising and many are calling for public schemes to 
incorporate private providers to increase efficiency and equity 
[22,23]. 
Edith Patouillard and colleagues conducted a systematic 
review of whether the for-profit sector, both formal and 
informal, could help improve health care for the poor. 
They found 52 evaluated interventions and concluded that 
despite limited evidence, “many interventions have worked 
successfully in poor communities” [1].
Loevinsohn and Harding reviewed ten studies in which 
public authorities in developing countries had contracted 
with private organisations [24]. All ten found that use of the 
private sector produced positive results, and importantly, 
the more rigorous the study the more positive the results. 
The review showed that private contractors can operate on a 
large scale, be more cost effective than government-provided 
services, and increase coverage in poor and remote areas. 
In six studies that directly compared private with public 
provision, all found that the private sector did better on 
multiple measures of quality and coverage. Contracting to 
the private sector for immunisation services in Cambodia, for 
example, increased coverage by 40% compared with only a 
19% increase using public providers. Also in Cambodia, when 
agreements with private providers specifically included targets 
for reaching the poor, equity was improved. 
The current health systems “crisis” in low-income countries 
results from decades of neglect in the areas of finance, 
service delivery, and infrastructure. Many countries, and 
the donors that have supported them, have tried to address 
these challenges through an implicit policy of creating a 
public sector monopoly, ignoring the large and growing 
private sector gorilla in the room. Some countries are now 
exploring pluralistic models that partner with the private 
sector to serve public policy goals. These models should be 
encouraged and supported. Improving health care for the 
world’s poor means harnessing everyone’s capacity, not just 
that of governments.
Hanson and Colleagues’ Response to Smith and 
Colleagues’ Viewpoint
Richard Smith and colleagues are forceful advocates for 
a greater role for the private sector in the health systems of 
low-income countries. Unfortunately, as they also recognise, 
the evidence to support their position is limited. In an era 
where national governments and donors are encouraged to 
embrace evidence-based policy making, blanket exhortations 
to harness the capacity of the private sector are unhelpful.
First, Smith and colleagues pay insufficient attention to the 
diversity of the private sector in developing countries. They 
cite data on sources of care from World Bank reports [13], 
but such data usually fail to capture this diversity, presenting 
results for all private sources together. Different types of 
providers offer different opportunities and threats for public 
health, and policies and interventions must be tailored to the 
provider type and context. For example, Smith and colleagues 
use evidence presented in the review by Loevinsohn and 
Harding [24] to advocate the use of private contractors, but 
fail to mention that many of the interventions cited in that 
paper involved non-governmental organisations. The lessons 
for working with private commercial providers are therefore 
unclear. 
Second, Smith and colleagues place considerable weight on 
the proportion of private spending in total health financing. 
However, this is an imperfect measure of the size of the 
private sector. For instance, significant amounts of out-of-
pocket spending go to public providers, through official user 
fees or informal charges, or go to purchase drugs and other 
inputs that are in short supply in public facilities. Moreover, 
high rates of out-of-pocket spending are a symptom of malaise 
in the health system rather than something to build on. 
There is abundant evidence of the potentially catastrophic 
impact of such payments on poor households [25]. Replacing 
out-of-pocket spending with private health insurance can 
bring its own problems in the form of coverage gaps and 
inefficiency. It is widely recognised that a strong public role in 
health spending (whether through payroll or general taxes) is 
essential for health systems to protect the poor [26]. Systems 
with the strongest state role have been shown to be the 
most equitable [27,28], and achieve better aggregate health 
outcomes [29]. 
Third, it is not true to say that governments and donors 
have completely ignored the private sector—the United 
States Agency for International Development, for example, 
has supported private sector provision initiatives since the 
mid-1980s [30]—but more attention to understanding the 
scale, scope, and effectiveness of this sector is certainly 
needed. The lack of evaluation of private sector initiatives 
is acute. For instance, in their systematic review Patouillard 
and colleagues identified no data on the impact of social 
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franchising in low-income settings on technical quality or 
health outcomes [1]—so any “widespread enthusiasm” for 
it is hardly warranted. Smith and colleagues suggest that 
responsibility for this failure to evaluate interventions lies 
with the government stewards of the sector, but most private 
sector interventions have been donor supported. The global 
public health community must commit to developing a strong 
evidence base on private sector engagement so that future 
debates can be grounded in better understanding. 
Smith and Colleagues’ Response to Hanson and 
Colleagues’ Viewpoint
These two Viewpoints agree much more than they disagree. 
Both agree that the public sector cannot be ignored and both 
agree that there is a role for the private sector in improving 
the health of the world’s poorest. The disagreement is about 
emphasis. We believe that many countries will benefit more 
from harnessing the energy of the private sector rather than 
continuing to invest solely or mainly in the public sector.
Five decades of attempts by governments in low-income 
countries to build state monopolies in health care have failed 
miserably in most of the poorest countries. Financing through 
general taxation is inadequate, and donor contributions are 
volatile and unreliable. Infrastructure has been allowed to 
decay, and service provision is often inequitable and of low 
quality [14,31–33]. Hanson and colleagues acknowledge these 
shortcomings. Our experience of working with health systems 
across the world is that the complexity of health care plus the 
bureaucracy and politicisation of government creates a lethal 
combination [8,34,35].
Hanson and colleagues mislead readers by repeating 
the familiar story of market failures. It is because of these 
inefficiencies that we are arguing for public–private 
partnerships, rather than simply the growth of an unregulated 
private sector.
We agree with Hanson and colleagues that more research 
is needed on the role of the private sector. But we have shown 
that there is more research than they may have recognised, 
and—importantly—this research points in the same 
direction, showing that the private sector can help the world’s 
poorest. The absence of evidence is not, however, the same as 
evidence of absence of effect. 
Policy makers and thought leaders in low- and middle-
income countries, confronted with continuing failures in 
the public sector, growing evidence of the effectiveness of 
the private sector, and energetic non-state organisations, 
are already working to harness the power of the private 
sector to achieve better health care for all. Evaluation will 
be crucial, but the most important research question is not 
“Can the private sector help?” but “How can public–private 
partnerships be made most effective and equitable?”
As Hanson and colleagues rightly urge, we must innovate 
and learn by doing. In well-structured public–private 
partnerships, the private partners are fully accountable 
for the delivery of specified services and outcomes, and 
arrangements for financial rewards and penalties require 
that there is rigorous measurement of process and outcomes. 
None of this is true in a public system. A poor woman with an 
obstetric emergency in a rural area of a low-income country 
is likely to die. Her death and its cause go unrecorded. No 
inquiry is made about this preventable loss of life. No one is 
held accountable. No question is asked in parliament. Her 
death is a silent tragedy. The private sector can help us do 
better. 
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